Acute generalized exanthematous pustulosis (AGEP) - A clinical reaction pattern

被引:571
作者
Sidoroff, A
Halevy, S
Bavinck, JNB
Vaillant, L
Roujeau, JC
机构
[1] Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria
[2] Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Univ Med Ctr, Dept Dermatol, Beer Sheva, Israel
[3] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands
[4] Univ Tours, Dept Dermatol, F-37041 Tours, France
[5] Univ Paris 12, Dept Dermatol, Creteil, France
关键词
D O I
10.1034/j.1600-0560.2001.028003113.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: A wide range of diseases or reactions can cause pustular eruptions of the skin. In this spectrum there seems to be a subgroup with characteristic clinical features and a typical course which is mostly caused by drugs for which the term acute generalized exanthematous pustulosis (AGEP) has been established. Objective: To describe the clinical features of AGEP. Methods: The authors' experience from a multinational epidemiological study on severe cutaneous adverse reactions and a comprehensive review of the literature were used to provide an overview of the disease and it's possible causes. An algorithm for validating cases which was established for this study is also presented. Results: AGEP typically presents with at least dozens of non follicular sterile pustules occurring on a diffuse, edematous erythema pre dominalty in the folds and/or on the face. Fever and elevated blood neutrophils are common. Histopathology typically shows spongiform subcorneal and/or intraepidermal pustules, a marked edema of the papillary dermis, and eventually vasculitis, eosinophils and/or focal necrosis of keratinocytes. Onset is acute, most often following drug intake, but viral infections can also trigger the disease. Pustules resolve spontaneously in less than 15 days. Conclusion: The diagnosis AGEP should be considered in cases of acute pustular rashes and detection of the causative drug should be strived for. Knowledge of the clinical features and usual course of this disease can often prevent unnecessary therapeutical measures.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 88 条
[1]   Acute generalized exanthematous pustulosis - A cutaneous adverse effect due to prophylactic antiviral therapy with protease inhibitor [J].
Aquilina, C ;
Viraben, R ;
Roueire, A .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (19) :2160-2161
[2]  
ARMSTER H, 1991, HAUTARZT, V42, P713
[3]  
ASSIER H, 1993, ANN DERMATOL VENER, V120, P848
[4]   Acute generalized exanthematous pustulosis induced by hydroxychloroquine [J].
AssierBonnet, H ;
Saada, V ;
Bernier, M ;
Clerici, T ;
Saiag, P .
DERMATOLOGY, 1996, 193 (01) :70-71
[5]  
AUERGRUMBACH P, 1995, BRIT J DERMATOL, V133, P9
[6]   GENERALIZED PUSTULAR PSORIASIS - A CLINICAL AND EPIDEMIOLOGICAL STUDY OF 104 CASES [J].
BAKER, H ;
RYAN, TJ .
BRITISH JOURNAL OF DERMATOLOGY, 1968, 80 (12) :771-&
[7]  
BALLMERWEBER BK, 1993, SCHWEIZ MED WSCHR, V123, P542
[8]   Acute contact dermatitis and exanthematous pustulosis due to mercury [J].
Barrazza, V ;
Meunier, P ;
Escande, JP .
CONTACT DERMATITIS, 1998, 38 (06) :361-361
[9]  
Bernard P., 1995, Annales de Dermatologie et de Venereologie, V122, pS38
[10]  
BERNARD P, 1989, ANN DERMATOL VENER, V116, P31